Arunima Dutta, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 S Kitsap Blvd Ste 210, Port Orchard, WA 98366 Phone: 360-874-5900 Fax: 360-874-5959 |
Dr. Adrienne M Lopata, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 451 Sw Sedgwick Rd, Suite 110, Port Orchard, WA 98367 Phone: 360-874-5900 Fax: 360-874-5959 |
Dr. Hector Decena Reyes Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 450 S Kitsap Blvd, Port Orchard, WA 98366 Phone: 360-874-5900 Fax: 253-530-2970 |
Dr. Andrew James Luk, MD, MPH Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 450 So. Kitsap Blvd, Suite 200, Port Orchard, WA 98366 Phone: 360-744-6250 Fax: 360-744-6296 |
James Richard Bates, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 450 S Kitsap Blvd, Bldg. 1, Suite 250, Port Orchard, WA 98366 Phone: 360-782-3000 Fax: 360-782-3040 |
Young-ki Paik, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 S Kitsap Blvd, Suite 250, Port Orchard, WA 98366 Phone: 360-782-3001 Fax: 360-782-3040 |
Dr. Thomas T Siler Jr., MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1400 Pottery Ave, Port Orchard, WA 98366 Phone: 360-895-5000 |
Safoora Zaka, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 450 S Kitsap Blvd, Suite 2860, Port Orchard, WA 98366 Phone: 360-782-3000 |
Niharika Chimalakonda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 S Kitsap Blvd Ste 250, Port Orchard, WA 98366 Phone: 360-782-3000 Fax: 360-782-3040 |
Regina B Bonnevie-rogers, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 S Kitsap Blvd, Port Orchard, WA 98366 Phone: 360-876-7215 Fax: 360-876-6721 |
News Archive
A study of young adult rats by researchers from the Johns Hopkins Bloomberg School of Public Health provides evidence that explains exactly how exposure to lead during brain development produces learning deficits.
Positron emission tomography (PET) could be an important tool for identifying non-Hodgkin's lymphoma patients who are likely to respond well to treatment with 90 ibritumomab tiuxetan (IT)-the first radioimmunotherapy treatment approved for use by the U.S. Food and Drug Administration, said researchers at the Society of Nuclear Medicine's 55th Annual Meeting.
Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA's review to be completed in the first half of 2013.
› Verified 1 days ago